Leaving less up in the air: Considerations for severe asthma

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

(BPT) - Sponsored by GSK

You do your best to manage severe asthma, often taking multiple therapies to keep asthma attacks at bay.1 Still, life may feel "up in the air" - like your treatments leave your symptoms feeling unpredictable.1,2

If you're currently on treatment for severe asthma but still dealing with symptoms and attacks, it may be time for a conversation with your doctor - one that explores whether your current regimen is addressing a root cause of severe asthma.2,3

Here are five things to know about severe asthma that may help you reduce severe asthma attacks:

1. Your asthma can be unpredictable

Even if you're doing your best to manage asthma, you may still be dealing with symptoms.2,3 Many patients accept ongoing frustration with frequent symptoms as the norm, but it doesn't have to be.4 Continued symptoms and flare-ups could be signs your treatment might not be fully addressing the problem.2,3

2. Chronic inflammation may be a root cause

When it comes to asthma, chronic inflammation in the lungs plays an important role. For 80% of people with severe asthma, the disease is driven by a specific underlying issue called Type 2 inflammation.3,5 Uncontrolled inflammation in your lungs can cause attacks, make your asthma even worse, and can lead to hospitalization or ER visits.1,6 Knowing if you have uncontrolled asthma can help you assess your current treatment and if it's working for you.

Woman in park with inhaler. Ask your doctor about a different type of asthma control. Learn more at asthma.com.


3. When to consider a more targeted approach

If you're wondering if a targeted treatment might be an option for you, there are a few questions to ask yourself. If you've had at least two asthma attacks in the past year or have been hospitalized for your asthma, it may be time to talk to your doctor.3

Ariel view of woman and her dog on a picnic with a basket and blanket. Learn more about asthma at asthma.com.


4. Biologic treatments offer a different way to treat asthma

Biologic treatments target certain parts of the immune system to help manage inflammation.1,3 Biologic treatments can be added to an existing regimen for some cases of asthma.1,3

Woman wearing a helmet on a bike ride in the park. Learn more about asthma asthma.com.


5. Talk to an asthma specialist about your treatment goals

Opening up about challenges isn't always easy, but it's key to meeting your goals and keeping your asthma management on track. There are several types of asthma specialists - pulmonologists, allergists and immunologists - that can help you make informed treatment decisions and explore options you may not have considered.

null

It may be time to ask your doctor about a different type of asthma control. Learn more at asthma.com.




[1] De Graaff, M. B., et al. "'like a fish on dry land': An explorative qualitative study into severe asthma and the impact of biologicals on patients' everyday life." Journal of Asthma, vol. 59, no. 5, 24 Feb. 2021, pp. 980-988, https://doi.org/10.1080/02770903.2021.1888976.

[2] Busse, William W., et al. "Holy Grail: The journey towards disease modification in asthma." European Respiratory Review, vol. 31, no. 163, 22 Feb. 2022, p. 210183, https://doi.org/10.1183/16000617.0183-2021.

[3] Venkatesan, Priya. "2025 GINA Report for Asthma." The Lancet Respiratory Medicine, vol. 13, no. 8, Aug. 2025, https://doi.org/10.1016/s2213-2600(25)00242-5.

[4] Bidad, Natalie, et al. "Understanding patients' perceptions of asthma control: A qualitative study." European Respiratory Journal, vol. 51, no. 6, 17 May 2018, p. 1701346, https://doi.org/10.1183/13993003.01346-2017.

[5] Heaney, L, et al. "Eosinophilic and noneosinophilic asthma." CHEST, vol. 160, no. 3, Sept. 2021, pp. 814-830, https://doi.org/10.1016/j.chest.2021.04.013

[6] Çolak, Yunus, et al. "Type-2 inflammation and lung function decline in chronic airway disease in the general population." Thorax, vol. 79, no. 4, 9 Jan. 2024, pp. 349-358, https://doi.org/10.1136/thorax-2023-220972.

Sponsored by GSK
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.39
+6.89 (2.90%)
AAPL  298.01
+2.06 (0.70%)
AMD  537.37
+24.89 (4.86%)
BAC  56.20
-0.33 (-0.58%)
GOOG  367.46
+5.36 (1.48%)
META  577.22
+9.64 (1.70%)
MSFT  379.40
+0.49 (0.13%)
NVDA  210.69
+6.04 (2.95%)
ORCL  184.29
+0.76 (0.41%)
TSLA  400.49
+4.11 (1.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.